Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Burn

Showing results (81-90 of 561) with videos related to

Pageof 57
Sort By:
Neurology|March 1, 1993
Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET studyD J Burn, D J Brooks
Clinical Endocrinology|April 1, 1985
A case of 'essential' hypernatraemia due to resetting of the osmostatG Gill, P Baylis, J Burn
BMJ (Clinical Research Ed.)|April 28, 2001
Three views of genetics: the enthusiast, the visionary, and the sceptic. Interview by Tessa RichardsJ Burn, G Duff, N Holtzman
The Lancet. Neurology|July 10, 2003
Progressive supranuclear palsy: where are we now?David J Burn, Andrew J Lees
Handbook of Clinical Neurology|September 24, 2008
Progressive supranuclear palsyDavid J Burn, Andrew J Lees
Archives of Disease in Childhood|April 1, 1982
Liver damage in a neonate with alpha-1-antitrypsin deficiency due to phenotype PiZ null (Z-)J Burn, D Dunger, B Lake
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's diseaseDavid J Burn, Ian G McKeith
Practical Neurology|March 8, 2013
Mild cognitive impairment in Parkinson's disease: millstone or milestone?David J Burn, Roger A Barker
Bailliere'S Clinical Obstetrics and Gynaecology|September 1, 1987
Congenital anomalies in twinsE Bryan, J Little, J Burn
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2011
The interplay of cholinergic function, attention, and falls in Parkinson's diseaseAlison Yarnall, Lynn Rochester, David J Burn
Pageof 57

Showing results (81-90 of 561) with videos related to

Sort By:
Pageof 57
Neurology|March 1, 1993
Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET studyD J Burn, D J Brooks
Clinical Endocrinology|April 1, 1985
A case of 'essential' hypernatraemia due to resetting of the osmostatG Gill, P Baylis, J Burn
BMJ (Clinical Research Ed.)|April 28, 2001
Three views of genetics: the enthusiast, the visionary, and the sceptic. Interview by Tessa RichardsJ Burn, G Duff, N Holtzman
The Lancet. Neurology|July 10, 2003
Progressive supranuclear palsy: where are we now?David J Burn, Andrew J Lees
Handbook of Clinical Neurology|September 24, 2008
Progressive supranuclear palsyDavid J Burn, Andrew J Lees
Archives of Disease in Childhood|April 1, 1982
Liver damage in a neonate with alpha-1-antitrypsin deficiency due to phenotype PiZ null (Z-)J Burn, D Dunger, B Lake
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2003
Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's diseaseDavid J Burn, Ian G McKeith
Practical Neurology|March 8, 2013
Mild cognitive impairment in Parkinson's disease: millstone or milestone?David J Burn, Roger A Barker
Bailliere'S Clinical Obstetrics and Gynaecology|September 1, 1987
Congenital anomalies in twinsE Bryan, J Little, J Burn
Movement Disorders : Official Journal of the Movement Disorder Society|September 8, 2011
The interplay of cholinergic function, attention, and falls in Parkinson's diseaseAlison Yarnall, Lynn Rochester, David J Burn
Pageof 57